{
  "url": "https://openlegislation.uk/draft-genetically-modified-organisms-deliberate-release-etc-miscellaneous-amendments-scotland-regulations-2019/regulation-7",
  "json_url": "https://openlegislation.uk/draft-genetically-modified-organisms-deliberate-release-etc-miscellaneous-amendments-scotland-regulations-2019/regulation-7.json",
  "legislation": "sdsi/2019/9780111040584",
  "legislation_title": "The Genetically Modified Organisms (Deliberate Release etc.) (Miscellaneous Amendments) (Scotland) Regulations 2019",
  "legislation_url": "https://openlegislation.uk/draft-genetically-modified-organisms-deliberate-release-etc-miscellaneous-amendments-scotland-regulations-2019",
  "path": "regulation/7",
  "kind": "regulation",
  "number": "7",
  "heading": "Amendment to the Genetically Modified Organisms (Deliberate Release) (Scotland) Regulations 2002",
  "text": "In regulation 15 (exempt activities)—\n(a) the existing text becomes paragraph (1),\n(b) in sub-paragraph (e), for the words from “Regulation (EC) No. 726/2004” to “Agency”, substitute “Regulation (EC) No 726/2004 of the European Parliament and of the Council laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency”,\n(c) at the end of sub-paragraph (e), after “marketed;” insert “and”,\n(d) omit—\n(i) sub-paragraph (f), and\n(ii) the word “and” immediately following that sub-paragraph, and\n(e) after paragraph (1) insert—\n“(2) In paragraph (1)(e), “Regulation 2309/93” means Council Regulation (EEC) No 2309/93 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products, as it had effect before it was repealed by Regulation (EC) No 726/2004 of the European Parliament and of the Council laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "OJ L 136, 30.4.2004, p.1, as last amended by Regulation (EU) No 1027/2012 of the European Parliament and of the Council (OJ L 316, 14.11.2012, p.38)."
    },
    {
      "type": "footnote",
      "label": "f2",
      "text": "OJ L 214, 24.8.1993, p.1, as amended by Commission Regulation (EC) No 649/98 (OJ L 88, 24.3.1998, p.7), Council Regulation (EC) No 807/2003 (OJ L 122, 16.5.2003, p.36), and Commission Regulation (EC) No 1647/2003 (OJ L 245, 29.9.2003, p.19)."
    },
    {
      "type": "footnote",
      "label": "f3",
      "text": "OJ L 136, 30.4.2004, p.1."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/sdsi/2019/9780111040584/regulation/7",
    "retrieved_at": "2026-10-30T15:32:56.708155+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}